Olon SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Olon SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH143000D
  • |
  • Pages: 21
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Olon SpA (Olon), formerly Antibioticos SpA, a susbsidiary of P&R S.p.A. is a developer and producer of active pharmaceutical ingredients. The company offers products such as azacitidine, bezafibrate, ibuprofen sodium, acamprosate calcium, acebutolol hydrochloride, acitretin, thalidomide, abacavir sulfate, etretinate, doxorubicin hydrochloride, abiraterone acetate, rifampycin and pridinol mesylate, among others. Its products are used in the therapeutic areas such as muscle relaxant, antibacterial, anticholinergic, antibiotic, anti-parkinson, mucolitic, hepatoprotectant, diuretic, antiviral, antineoplastic, alcohol dependence treatment, bronchodilator, HIV proteinase inhibitor, anxiolytic, lipoprotein disorders and exclusive parenteral feeding. Olon also provides custom synthesis and contract manufacturing services. The company operates through its manufacturing facilities located in Italy and Spain. Olon is headquartered in Rodano, Italy.

Olon SpA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Olon SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Olon SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Olon SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Olon SpA, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Olon to Acquire API Manufacturing Facility from Novartis 10

Olon Acquires Chemical Division from Ricerca Biosciences 11

Private Equity 12

Main Market Partners Acquires Ricerca Biosciences 12

Asset Transactions 13

Olon Acquires Chemical Division from Ricerca Biosciences 13

WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 14

Salix Pharma Acquires Worldwide IP Rights To Amorphous Rifaximin From Olon 15

Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 16

Acquisition 17

Frontage Laboratories Acquires Concord Biosciences 17

Olon to Acquire Infa Group 18

Olon SpA-Key Competitors 19

Olon SpA-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Research And Development 20

Jan 26, 2018: Olon Announces Investment and Expansion of APIs Manufacturing Capabilities 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21

List of Figures

Olon SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Olon SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Olon SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Olon SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Olon SpA, Pharmaceuticals & Healthcare, Key Facts 2

Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Olon SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Olon SpA, Deals By Therapy Area, 2012 to YTD 2018 8

Olon SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Olon to Acquire API Manufacturing Facility from Novartis 10

Olon Acquires Chemical Division from Ricerca Biosciences 11

Main Market Partners Acquires Ricerca Biosciences 12

Olon Acquires Chemical Division from Ricerca Biosciences 13

WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 14

Salix Pharma Acquires Worldwide IP Rights To Amorphous Rifaximin From Olon 15

Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 16

Frontage Laboratories Acquires Concord Biosciences 17

Olon to Acquire Infa Group 18

Olon SpA, Key Competitors 19

Olon SpA, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Olon SpA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17743
Site License
USD 500 INR 35485
Corporate User License
USD 750 INR 53228

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com